MARKETS / COMPANIES / ECONOMYRSS edition ↗
Capital Monitor
Market News

Paras Healthcare IPO Day 2: GMP at 4%; check subscription status and key details

Benchmarks Nifty22,724.30-87.05FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.76 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.76 % Invest NowEnter search…

Paras Healthcare IPO Day 2: GMP at 4%; check subscription status and key details
Benchmarks Nifty22,724.30-87.05FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.76 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.76 % Invest NowEnter search text:
    The Economic Times daily newspaper is available online now. Read Today's Paper Paras Healthcare IPO Day 2: GMP at 4%; check subscription status and key detailsBy Ritesh Presswala, ETMarkets.comLast Updated: Oct 22, 2026, 10:46:00 AM ISTSynopsis

    Paras Healthcare has launched its IPO, starting on October 21 and concluding on October 23. By October 22, participation had reached only 15% overall, yet retail investor involvement surged to 69%. The funds raised are intended for debt repayment and general corporate uses. In Fiscal Year 2026, Paras Healthcare reported a notable profit of Rs 44 crore. Shares are expected to be listed by October 28, 2026.

    Paras Healthcare's IPO entered its second day of bidding on Thursday, October 22, amid a muted response from investors. In the grey market, the issue is commanding a premium of around 4%, indicating expectations of a modest listing gain over the issue price.

    On Day 1, the IPO was subscribed 15% overall against 1.20 crore shares on offer. The retail individual investor (RII) portion was subscribed 69% against 21.96 lakh shares reserved for the category.

    The public issue opened on October 21, 2026, and will remain open for subscription until October 23, giving investors a three-day bidding window.

    The Rs 1,450 crore IPO comprises a fresh issue of 72.15 lakh shares worth Rs 500 crore and an offer for sale (OFS) of 1.37 crore shares aggregating to Rs 950 crore.

    Paras Healthcare has fixed the IPO price band at Rs 660–Rs 693 per share, with a lot size of 21 shares. At the upper end of the price band, retail investors need to invest a minimum of Rs 14,553 to apply for one lot.

    Live Events


        The basis of allotment is expected to be finalised on October 26, while the shares are tentatively scheduled to list on the BSE and NSE on October 28, 2026.

        JM Financial Ltd., BofA Securities India Ltd. and Nuvama Wealth Management Ltd. are the book-running lead managers for the issue, while MUFG Intime India Pvt. Ltd. is the registrar.

        Paras Healthcare IPO: Anchor investor details

        Paras Healthcare raised Rs 652.5 crore from anchor investors on October 19, a day before the IPO opened for public subscription. The anchor investors included Abu Dhabi Investment Authority, BlackRock Global Funds, Eastspring Investments, Government Pension Fund Global, Natixis International Funds, Integrated Core Strategies (Asia) and Citigroup Global.

        Paras Healthcare's IPO received a muted response on the first day of bidding, with the issue subscribed 15% overall against 1.20 crore shares on offer.

        The retail individual investor (RII) portion was subscribed 69% against 21.96 lakh shares reserved for the category. The non-institutional investor (NII) segment saw a subscription of 8% against 32.95 lakh shares allocated to the category.

        Meanwhile, the qualified institutional buyer (QIB) portion had yet to receive any bids against the 65.90 lakh shares reserved for the segment.

        Paras Healthcare IPO GMP Today

        Paras Healthcare IPO is commanding a grey market premium (GMP) of Rs 25 per share, translating into a premium of around 4% over the upper end of the issue price band of Rs 693. Based on the prevailing GMP, the estimated listing price works out to approximately Rs 718 per share.

        IPO Objects of the Issue

        The company plans to utilise Rs 320.90 crore from the net proceeds of the IPO to prepay or repay, either fully or partially, certain outstanding borrowings availed by the company. Additionally, Rs 54.10 crore will be invested in its wholly owned subsidiary, PMHPL, which operates a hospital in Srinagar, to facilitate the full or partial repayment or prepayment of its outstanding borrowings.

        The remaining proceeds will be allocated towards general corporate purposes. Of the total IPO proceeds of Rs 375 crore, the primary objective is to reduce the company's debt burden, strengthen its financial position and support its overall corporate requirements.

        Financials Performance

        Paras Healthcare Ltd. reported a 24% year-on-year increase in total income to Rs 1,629 crore in FY26, compared with Rs 1,314 crore in FY25. The company also turned profitable, posting a profit after tax (PAT) of Rs 44 crore in FY26, against a loss of Rs 58 crore in the previous financial year.

        About Paras Healthcare

        Incorporated in1987, Paras Healthcare Limited is a leading clinical specialty-led hospital platform providing tertiary and quaternary healthcare services across North India, Bihar, and Jharkhand under the "Paras Health" brand. The company operates eight hospitals with an aggregate bed capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar as of June 30, 2026.

        It specializes in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics & sports injury, and renal sciences (CONGOR specialties), which contributed 75.30% of revenue in Fiscal 2026. Paras Healthcare has over 20 years of operating history and follows a balanced growth strategy through mature, emerging, and new hospitals. The company plans to expand its network with a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana, increasing total capacity to 3,011 beds by March 2028. As of March 31, 2026, it had 4,670 employees, including 1,084 doctors and 1,937 nurses.

        Disclaimer: The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here
        Add as a Reliable and Trusted News Source Add Now!
        (You can now subscribe to our ETMarkets WhatsApp channel)
        Read More News onParas Healthcare IPOParas HealthcareIPO subscription statusGMPAnchor investorsjm financial ltd.nuvama wealth management ltd.

        (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

        Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

        ...moreless
        (You can now subscribe to our ETMarkets WhatsApp channel)
        Read More News onParas Healthcare IPOParas HealthcareIPO subscription statusGMPAnchor investorsjm financial ltd.nuvama wealth management ltd.

        (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

        Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

        ...morelessPrime ExclusivesInvestment IdeasStock Report PlusePaperWealth Edition
        • The global business of promising more

        • One company, 2 words. Bond yield and CDS: Will they decide the fate of global markets?

        • Business of Odd Things: Inside an industry that farms fish that nobody is meant to eat

        • War's second-order effects are becoming visible in critical sectors

        • US mid-term elections – Part 2: What does it mean for Trump to lose control of Congress?

        • Homebuyers wait as NCLT panel picks holes in unfinished Jaypee projects

        • 1
        • 2
        • 3
        View all StoriesContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories
        & personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions &
        in-depth stock reportsSubscribe NowET

        Unlock Access to All Exclusives with ETPrime FREE TRIAL

        15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers

        Trial offer expiring in00 : 05 : 00

        I'd rather pay ₹2599 now

        Uh-oh! This is an exclusive story available for selected readers only.

        Worry not. You’re just a step away.

        Prime Account Detected!

        It seems like you're already an ETPrime member with

        Login using your ET Prime credentials to enjoy all member benefits

        Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.

        Unlock ETPrime's Exclusive Stories Today!

        Big Price Drop! Flat 40% Off

        Student Only OfferAlready a Member? Sign In nowAlready a Member? Sign In nowAlready a Member? Sign In now

        Offer Exclusively For You

        Save up to Rs. 700/-

        ON ET PRIME MEMBERSHIP

        Avail Offer

        Offer Exclusively For You

        Get 1 Year Free

        With 1 and 2-Year ET prime membership

        Avail Offer

        Offer Exclusively For You

        Get 1 Year Free

        With 1 and 2-Year ET prime membership

        Avail Offer

        Offer Exclusively For You

        Get Flat 40% Off

        Then ₹ 1749 for 1 year

        Avail Offer

        Offer Exclusively For You

        ET Prime at ₹ 49 for 1 month

        Then ₹ 1749 for 1 year

        Avail Offer

        Special Offer

        Get flat 40% off on ETPrime

        Avail OfferAvail OfferClaim NowAlready a Member? Sign In now

        Need Assistance?

        Connect with an ETPrime expert for personalized support and guidance

        +91 9484700004'; }); } if(listing) { var h3 = "You tried reading " + listArr.length + " locked stories in the past " + threshold + " days.", h4 = "Become an ET Prime member and don't miss out on these exclusive stories."; var html = '

        ' + h3 + '

        ' + h4 + '

          ' + listing + '
        '; $('#paidSCWidget').html(html); var callback = $('#paidSCWidget').attr('data-callback'); if(callback && window[callback]) { window[callback](); } customDimension.dimension72 += ' | Shown SYFT no Trial_With Missed Paywalled Articles Collection'; } else { _processNormal() } } }); } else { _processNormal(); } } catch (e) { _processNormal(); } }, function () { _processNormal(); }); //console.log('storyCollectionLoad', $); }

        What’s Included with

        ETPrime Membership

        1Exclusive Insights That Matter

        Uncover the truth with our investigative stories

        Make strategic moves using the real-world case studies

        Read industry-specific stories to identify emerging trends

        Spot opportunities with
in-depth insights that matter

        • Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

          What Adani’s US indictment means for India Inc’s overseas fundraising

        • Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

          Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?

        • Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

          The problem with lab grown diamonds

        • Why a falling rupee is a better option for the economy

          A list of top 20 momentum stocks that have delivered massive returns in one year

          2Invest Wisely With Smart Market Tools & Investment Ideas

          Alpha Trade

          Get daily trade ideas from SEBI-registered research analysts.

          Investment Ideas

          Grow your wealth with stock ideas & sectoral trends.

          Stock Reports Plus

          All-in-one stock research with Stock Score, peer comparison & key signals.

          BigBull Portfolio

          Get to know where the market bulls are investing to identify the right stocks.

          Stock Analyzer

          Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.

          Market Mood

          Analyze the market sentiments & identify the trend reversal for strategic decisions.

          Stock Talk Live at 9 AM Daily

          Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.

          3Stay informed anytime, anywhere with ET ePaper

          ePaper - Print View

          Read the PDF version of ET newspaper. Download & access it offline anytime.

          ePaper - Digital View

          Read your daily newspaper in Digital View & get it delivered to your inbox everyday.

          Wealth Edition

          Manage your money efficiently with this weekly money management guide.

          TOI ePaper

          Read the PDF version of TOI newspaper. Download & access it offline anytime.

          Deep Explainers

          Explore the In-depth explanation of complex topics for everyday life decisions.

          Health+ Stories

          Get fitter with daily health insights committed to your well-being.

          Personal Finance+ Stories

          Manage your wealth better with in-depth insights & updates on finance.

          5Enjoy Complimentary Subscriptions From Top Brands

          Stream new documentaries from all across the world every day.

          Stories you might be interested in

            Source: Economic Times — IPOs/FPOs ↗

            Figures reflect the source report and its stated period. This article is for information and is not investment advice.